Search
Pharmamar, leaders in marine-based biotechnology

PharmaMar is a Spanish member of the Zeltia Group, a leader in the development of antitumor drugs of marine origin.

The oceans cover 70% of the Earth's surface, and correspond to 90% of the biosphere. For millions of years, innumerable forms of marine life have evolved to produce an immense variety of chemical entities of exclusive sophistication. Among these, there are molecules with potent biological activities, developed as a form of biochemical warfare to survive in an extremely competitive environment. PharmaMar has identified the antitumour potential of these molecules, and is actively developing them as innovative treatments for cancer.

One of the company's commitments is to develop drugs to treat rare ("orphan") diseases, i.e. those affecting under 5 out of every 100,000 people, according to the EU's definition. PharmaMar has a strong portfolio of marine origin compounds in development

We research to provide solutions that improve the quality of life of cancer patients and their families.

Library of 200'000 extracts from 100´000 different marine organisms available for drug screening

R&D areas at PharmaMar
Development of a marine new drug: an amazing and unique project
Near events
<agosto de 2014>
lmmjvsd
28293031123
45678910
11121314151617
18192021222324
25262728293031
1234567
Asebio
Copyright ©2014 Pharmamar. All rights reserved. Disclaimer.
Zeltia